Evidence map›Paper›PMID 34034748›Full record

ArticleLipids in health and disease2021

A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test.

Xiaoyu Hou, Yunpeng Guan, Yong Tang, An Song, Jiajun Zhao, Luping Ren, Shuchun Chen, Limin Wei, Huijuan Ma, Guangyao Song

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biomolecules · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. SIRT3 rs11246020 Polymorphism Associated Postprandial Triglyceride Dysmetabolism.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  11. Serum Gamma Glutamyltransferase: A Biomarker for Identifying Postprandial Hypertriglyceridemia.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xiaoyu Hou *Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.
Yunpeng Guan *Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.
Yong TangDepartment of Endocrinology, Hebei General Hospital, 348, Heping West Road, Shijiazhuang, Hebei, 050051, People's Republic of China.
An SongKey laboratory of Endocrinology, Ministry of Health, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Jiajun ZhaoDepartment of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China.
Luping RenDepartment of Endocrinology, Hebei General Hospital, 348, Heping West Road, Shijiazhuang, Hebei, 050051, People's Republic of China.
Shuchun ChenDepartment of Endocrinology, Hebei General Hospital, 348, Heping West Road, Shijiazhuang, Hebei, 050051, People's Republic of China.
Limin WeiDepartment of Endocrinology, Hebei General Hospital, 348, Heping West Road, Shijiazhuang, Hebei, 050051, People's Republic of China.
Huijuan MaDepartment of Endocrinology, Hebei General Hospital, 348, Heping West Road, Shijiazhuang, Hebei, 050051, People's Republic of China.
Guangyao SongDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China. sguangyao2@163.com.ORCID http://orcid.org/0000-0002-9901-6074
Hebei General Hospital · CNHebei Medical University · CNShandong University · CN

Funding

Hebei Province Science and Technology Support Program zh2018001
6 · The paper itself

Abstract

backgroundNonalcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver diseases worldwide. Triglyceride (TG) accumulation is central to NAFLD development. People now spend most of their day in the postprandial state, and the measurement of postprandial blood lipid concentration can make up for the lack of simple detection of fasting blood lipids. Postprandial triglyceride (PTG) is commonly used as a surrogate for postprandial blood lipid concentrations, and many studies have shown that PTG is a risk factor for NAFLD. The aim of the present study was to investigate the relationship between PTG concentration during oral fat tolerance testing (OFTT) and NAFLD.

methodsA total of 472 Chinese adults, aged 25 to 65 years, were enrolled in the study. All the participants underwent OFTT. The serum concentrations of TG and other lipids were measured, and their relationships with NAFLD were analyzed.

resultsOf the 472 participants, 155 were diagnosed with NAFLD. The fasting and postprandial TG concentrations of the participants with NAFLD were higher than those of healthy participants (P < 0.05). The TG concentrations of the healthy participants peaked 4 h postprandially, whereas those of the participants with NAFLD peaked 6 h postprandially and reached higher peak values. Postprandial TG concentration was significantly associated with a higher risk of NAFLD.

conclusionsHigh PTG is positively related to a higher risk of NAFLD, and the PTG concentrations of patients with NAFLD are higher than in healthy individuals, with a delayed peak. Therefore, 4-h PTG may represent a potential marker of NAFLD.

trial registrationChiCTR1800019514 .

Indexed as

AdultBiomarkersBlood GlucoseBlood PressureBody Mass IndexChinaCholesterol, HDLCholesterol, LDLDietary FatsDyslipidemiasFemaleHumansLiver Function TestsMaleMiddle AgedNon-alcoholic Fatty Liver DiseaseBiomarkersBlood GlucoseCholesterol, HDLCholesterol, LDLDietary FatsTriglyceridesClinical studyDyslipidemiaNonalcoholic fatty liver diseaseOral fat tolerance testPostprandial lipidemiaTriglyceride

Identifiers

PMID34034748
PMCPMC8152134
OpenAlexW3164101818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.